Immunefi vs Injective
Funding, tech stack, customers, and competitors compared
Immunefi
Immunefi (immunefi.com) operates in an unconfirmed vertical; the domain name suggests a connection between security ('immune') and finance or DeFi ('fi'), but no readable website content was available to confirm business model, products, or customer segments.
Injective
Injective is a Layer-1 blockchain protocol purpose-built for decentralized finance (DeFi) applications, enabling developers to build financial dApps including decentralized exchanges, derivatives protocols, and lending markets. The protocol targets crypto-native developers and DeFi users seeking high-throughput, low-cost financial infrastructure.
| Dimension | Immunefi | Injective |
|---|---|---|
| Vertical | Other | FinServ |
| Segment | Other | FinTech |
| Founded | 2020 | 2018older |
| Employees | 11-50 | 51-200larger |
| Location | ||
| Funding | Series A ($35.5M) | |
| G2 Rating | ||
| Pricing Page | ||
| HTTPS |
Notable Customers
Immunefi
Injective
Known Competitors
Immunefi
Injective
Recent News
Immunefi
- Announcements - The Immunefi Blog
- Immunefi and Ripple Announce $200000 Attackathon to ...
- Immunefi and Movement Labs Launch ...
Injective
- Injective Announces Launch of INJ and Staking on Revolut
- Injective in the News | Latest Press & Updates
- Welcome to the Injective Era: Native EVM Mainnet Launch ...
Go deeper on both
Full profiles include buying signals, pain signals, account scoring, and recommended contacts. Profile either company free with 3 credits per week.
Start profiling freeThis is the free comparison
Full profiles add buying signals, pain signals, account scoring, and recommended contacts. Run one free, 3 credits per week, no card required.